Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness

被引:79
|
作者
Sunbul, Murat [1 ]
Agirbasli, Mehmet [1 ]
Durmus, Erdal [2 ]
Kivrak, Tarik [3 ]
Akin, Hakan [4 ]
Aydin, Yucel [4 ]
Ergelen, Rabia [5 ]
Yilmaz, Yusuf [4 ,6 ]
机构
[1] Marmara Univ, Sch Med, Dept Cardiol, TR-34840 Istanbul, Turkey
[2] Silifke State Hosp, Cardiol Clin, Mersin, Turkey
[3] Sivas Numune Hosp, Cardiol Clin, Sivas, Turkey
[4] Marmara Univ, Sch Med, Dept Gastroenterol, TR-34840 Istanbul, Turkey
[5] Marmara Univ, Sch Med, Dept Radiol, TR-34840 Istanbul, Turkey
[6] Marmara Univ, Inst Gastroenterol, TR-34840 Istanbul, Turkey
关键词
Nonalcoholic fatty liver disease; Arterial stiffness; Pulse wave velocity; Augmentation index; Epicardial fat thickness; PULSE-WAVE VELOCITY; METABOLIC SYNDROME; NAFLD; RISK;
D O I
10.1016/j.atherosclerosis.2014.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Non-alcoholic fatty liver disease (NAFLD) is associated with atherosclerosis and reduced vascular compliance. The purpose of this study was to examine the relationships between arterial stiffness measures, the histological severity of NAFLD, and epicardial fat thickness (EFT). Methods: A total of 100 patients with biopsy-proven NAFLD and 50 age-and sex-matched controls were enrolled. The histological severity was assessed in all NAFLD patients. Measurements of arterial stiffness [pulse-wave velocity (PWV) and augmentation index (AIx)] were carried out using a Mobil-O-Graph arteriograph system. EFT was assessed by means of echocardiography. Results: Compared with controls, NAFLD patients had significantly higher PWV and AIx values. Stepwise linear regression analysis demonstrated that the liver fibrosis score and EFT were independent predictors of both PWV and AIx values in NAFLD patients. Conclusions: Patients with NAFLD have an increased arterial stiffness, which reflects both the severity of liver fibrosis and increased EFT values. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:490 / 493
页数:4
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
    Tacke, Frank
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [42] Perivascular macrophages contribute to adipose tissue angiogenesis in patients with advanced non-alcoholic fatty liver disease
    Martinez-Sanchez, Celia
    Bassegoda, Octavi
    Berger, Hilmar
    Almodovar, Xenia
    Aguilar, Laia
    Fundora, Yilliam
    Ibarzabal, Ainitze
    de Hollanda, Ana
    Vidal, Pep
    Soria, Anna
    Luzko, Irina
    Guillamon, Alex
    Tacke, Frank
    Sancho-Bru, Pau
    Gines, Pere
    Graupera, Isabel
    JOURNAL OF HEPATOLOGY, 2023, 78 : S737 - S738
  • [43] Unravelling the landscape of adipose tissue macrophages in human non-alcoholic fatty liver disease
    Boesch, Markus
    Korf, Hannelie
    Feio de Azevedo, Rita Furtado
    Deleus, Ellen
    Lannoo, Matthias
    Smets, Lena
    Van Melkebeke, Lukas
    Wallays, Marie
    Roskams, Tania
    Bedossa, Pierre
    Lindhorst, Andreas
    Verbeek, Jef
    Voet, Thierry
    Sifrim, Alejandro
    Gericke, Martin
    van der Merwe, Schalk
    JOURNAL OF HEPATOLOGY, 2022, 77 : S680 - S681
  • [44] Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease
    Petta, S.
    Ciminnisi, S.
    Di Marco, V.
    Cabibi, D.
    Camma, C.
    Licata, A.
    Marchesini, G.
    Craxi, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (04) : 510 - 518
  • [45] Sarcopenia is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease
    Park, J. G.
    Kang, M. K.
    Baek, J. H.
    Park, S. Y.
    Lee, H. J.
    Hur, K.
    Tak, W. Y.
    Kweon, Y. O.
    Jang, S. Y.
    Lee, Y. R.
    Lee, H. W.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S838 - S838
  • [46] SARCOPENIA IS ASSOCIATED WITH SEVERE LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Petta, S.
    Ciminnisi, S.
    Di Marco, V.
    Camma, C.
    Craxi, A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S497 - S497
  • [47] Diabetes as a Risk Factor of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
    Trikola, Artemis
    Papastergiou, Basilios
    Mela, Maria
    Christidou, Angeliki
    Mountaki, Aikaterini
    Koustenis, Kanellos
    Veretanos, Christos
    Karaouzas, Lazaros
    Paparizou, Athanasia
    Arvanitis, Konstantinos
    Archavlis, Emmanouel
    Katopodi, Konstantina
    Viazis, Nikolaos
    Mantzaris, Gerassimos J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S973 - S973
  • [48] Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease
    Chan, Wah Kheong
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 183 - 184
  • [49] PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE, HIGH-RISK NON-ALCOHOLIC STEATOHEPATITIS, AND LIVER FIBROSIS IN PATIENTS WITH OSTEOARTHRITIS
    Kalligeros, Markos
    Vassilopoulos, Athanasios
    Vassilopoulos, Stephanos
    Wands, Jack R.
    Promrat, Kittichai
    HEPATOLOGY, 2023, 78 : S1034 - S1035
  • [50] Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease
    Parikh, Neal S.
    Wahbeh, Farah
    Tapia, Christopher
    Ianelli, Mallory
    Liao, Vanessa
    Jaywant, Abhishek
    Kamel, Hooman
    Kumar, Sonal
    Iadecola, Costantino
    BMJ NEUROLOGY OPEN, 2024, 6 (01)